# ğŸ“… Daily Report - 2025-12-21

> ä»Šæ—¥ç­›é€‰å‡º **53** æ¡å†…å®¹ï¼Œæ¥è‡ª **2** ä¸ªæ¥æº

<div class="powered-by-top">Powered by <a href="https://kyplus.de">ç§‘ç ”æ™®æ‹‰æ–¯</a> & <a href="https://claude.ai">Claude</a></div>

---

## ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“

### ğŸ§¬ æ•°æ®å‰æ²¿

> **ä»Šæ—¥ç„¦ç‚¹**ï¼š
æ–°å‹åŒé—¨æ§å·¨å™¬ç»†èƒ-ç»†èŒæ¿€æ´»å¹³å°ç”¨äºç²¾å‡†è‚¿ç˜¤å…ç–«æ²»ç–—ï¼›ç³»ç»Ÿè¯±å¯¼è®­ç»ƒæ€§å…ç–«å…‹æœå®ä½“ç˜¤å…ç–«æŠ‘åˆ¶å¾®ç¯å¢ƒã€‚

**ä¸»è¦æ–¹å‘**ï¼š
- **è‚¿ç˜¤å¾®ç¯å¢ƒé‡å¡‘ä¸å…ç–«æ¿€æ´»**ï¼šå¤šè¯è”åˆç–—æ³•ä¼˜åŒ–å¾®ç¯å¢ƒï¼Œå¢å¼ºå…ç–«ï¼›é”ŒæŒ‡è›‹ç™½Zbtb32ä¿ƒè¿›CD8+ Tç»†èƒåŠŸèƒ½ï¼›åŸºè´¨MTHFD2é©±åŠ¨è‚¿ç˜¤ç”Ÿé•¿ä¸å…ç–«é€ƒé€¸ï¼›å·¨å™¬ç»†èƒä»‹å¯¼çš„åŒç›¸æŠ—è‚¿ç˜¤æ•ˆåº”ã€‚
- **å‘è‚²ä¸ç–¾ç—…ä¸­çš„è¡¨è§‚é—ä¼ è°ƒæ§**ï¼šå¦Šå¨ æœŸå…ç–«æ¿€æ´»å¯¹ç¥ç»å‘è‚²çš„å½±å“ï¼›oxLDLå¯¹CD4+ Tç»†èƒè¡¨è§‚é—ä¼ æ ‡è®°çš„å½±å“ã€‚
- **ç™Œç—‡ç”Ÿç‰©å­¦ä¸è¯Šæ–­**ï¼šä¸‰é˜´æ€§ä¹³è…ºç™Œçš„ç»†èƒåˆ†å­å›¾è°±ä¸é¢„åï¼›PLPP1æŠ‘åˆ¶ä¹³è…ºç™Œç”Ÿé•¿ï¼›è¡°è€ç›¸å…³EXOSC2å¼‚å¸¸ä¸ç™Œç—‡ä¾èµ–æ€§ã€‚

**æŠ€æœ¯äº®ç‚¹**ï¼š
- **é«˜é€šé‡æµ‹åºæŠ€æœ¯**ï¼šRNA-seqã€ChIP-seqã€ATAC-seqç­‰å¹¿æ³›åº”ç”¨äºåŸºå› è¡¨è¾¾ã€æŸ“è‰²è´¨ç»“åˆå’ŒåŸºå› ç»„å¼€æ”¾æ€§ç ”ç©¶ã€‚
- **æ–°å‹å¹³å°ä¸æŠ€æœ¯**ï¼šå¾®ååº”å™¨ç³»ç»Ÿç”¨äºå³æ—¶ç—…æ¯’åŸºå› ç»„æµ‹åºï¼›å·¥ç¨‹åŒ–å·¨å™¬ç»†èƒç”¨äºä½“å†…åŒç›¸æŠ—è‚¿ç˜¤æ²»ç–—ã€‚

### ğŸ§ª åšå®¢æ›´æ–°

> **ä»Šæ—¥ç„¦ç‚¹**ï¼š
æ–°å‹çº¿ç²’ä½“èƒ½é‡ç”Ÿäº§è°ƒæ§ç­–ç•¥æ˜¾è‘—å»¶é•¿ç»†èƒå¯¿å‘½ï¼›â€œåƒåœ¾DNAâ€ä¸­å‘ç°è°ƒæ§é˜¿å°”èŒ¨æµ·é»˜ç—…ç›¸å…³è„‘ç»†èƒçš„å…³é”®å¼€å…³ã€‚

**ä¸»è¦æ–¹å‘**ï¼š
- æ¢ç´¢åŸºå› è½¬å½•è°ƒæ§ä¸è¡°è€çš„å…³ç³»ã€‚
- ä¼˜åŒ–çº¿ç²’ä½“åŠŸèƒ½ä»¥å»¶ç¼“è¡°è€ã€‚
- æ­ç¤ºéç¼–ç DNAåœ¨ç¥ç»é€€è¡Œæ€§ç–¾ç—…ä¸­çš„ä½œç”¨ã€‚
- ç ”ç©¶ç¤¾ä¼šè¡Œä¸ºå¯¹å¤§è„‘è¡°è€çš„å½±å“ã€‚

**æŠ€æœ¯äº®ç‚¹**ï¼š
- åˆ©ç”¨é«˜é€šé‡RNAæµ‹åºåˆ†æè½¬å½•å»¶ä¼¸å› å­å¯¹åŸºå› è¡¨è¾¾å’Œè¡°è€çš„å½±å“ã€‚
- é€šè¿‡åŸºå› å·¥ç¨‹æ”¹é€ çº¿ç²’ä½“è›‹ç™½ä»¥æå‡èƒ½é‡ç”Ÿäº§æ•ˆç‡ã€‚
- å®éªŒéªŒè¯å¤§é‡DNAè°ƒæ§å…ƒä»¶çš„åŠŸèƒ½ã€‚

---

## ğŸ“š åˆ†ç±»æµè§ˆ

<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ§¬ æ•°æ®å‰æ²¿ (49æ¡)</summary>

<div class="details-content" markdown="1">

#### è¯¦ç»†å†…å®¹ï¼ˆå‰10æ¡ï¼‰

**1.** â­ **GSE314254 ä¼˜åŒ–çš„å¤šè¯ç–—æ³•é‡å¡‘è‚¿ç˜¤å¾®ç¯å¢ƒå¹¶å¢å¼ºå¾®å«æ˜Ÿç¨³å®šå‹ç»“ç›´è‚ ç™Œçš„æŠ—è‚¿ç˜¤å…ç–«**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼štumorã€cancerã€immunityã€tumor microenvironment
- ğŸ“ **æè¿°**ï¼šContributors : Pablo H Lopez ; Patrycja Nowak-SliwinskaSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusFour low-dose tyrosine kinase inhibitor (TKI)â€“based ODCs were evaluated in murine AKP CRC organoids, co-culture systems with tumor-associated endothelial cells and immune cells, and in vivo syngeneic models. Among these, ODCDLD1 (regorafenib, vemurafenib, erlotinib HCl, selumetinib) showed the most potent inhibition of tumor organoid viability (âˆ¼90%), promoted leukocyte infiltration in co-cultures, and significantly upregulated endothelial adhesion molecules (ICAM-1, VCAM-1, E-selectin). In vivo, ODCDLD1 reduced tumor growth comparably to oxaliplatin but with a favorable toxicity profile. Immunofluorescence analysis revealed that both ODCDLD1 and oxaliplatin significantly reduced the population of proliferating cancer cells. Furthermore, ODCDLD1-based treatment recapitulated transcriptomic findings by showing a significant reduction in proliferating myofibroblasts, a key stromal component. Bulk RNA sequencing revealed that ODCDLD1, especially when combined with anti-PD-1, induced an immunologically â€œhotâ€ tumor microenvironment characterized by enhanced immune cell recruitment, reduced fibroblast and stem-like cell signatures, and upregulation of endothelial markers.
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314254)

**2.** â­ **GSE291419ï¼šåŸºäºåŒé—¨æ§å·¨å™¬ç»†èƒ-ç»†èŒæ¿€æ´»å¹³å°çš„ç²¾å‡†è‚¿ç˜¤å…ç–«ç–—æ³•**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼štumorã€macrophageã€regex:bacter(ia|ial|ium)ã€regex:immuno(logy|therapy|suppression)
- ğŸ“ **æè¿°**ï¼šContributors : Lin Li ; Leyang Wu ; Zichun HuaSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusImmunotherapy based on live microorganisms has shown promise in preclinical studies, but its clinical translation has been hampered by limited efficacy and innegligible toxicity. Here, we developed M-BLAST (Macrophage-Bacteria encapsulation Lytic Autoactivated Synergistic Therapeutics), a dual-gated macrophage-mediated bacterial tumor-targeted delivery and in situ activation system. M-BLAST incorporates density-regulated virulence-enhanced attenuated Salmonella strains as the therapeutic core, thermally-controlled GSDMD-N-expressing macrophages as the delivery vector, and copper selenide, a photothermal material, as a heat-shock â€œprimer.â€ Following systemic administration, localized near-infrared irradiation at the tumor site triggers macrophage pyroptosis, ensuring rapid and complete bacterial release. This disrupts the immunosuppressive tumor microenvironment and elicits a widespread cascading antitumor response just like a â€œimmune bombâ€, while dual-gating design of bacterial density and heat-shock ensures safety by preventing off-target activation in non-tumor regions. M-BLAST promises to enhance the therapeutic utility of living engineered bacteria for cancer while ensuring safety.
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE291419)

**3.** â­ **GSE297247 å¦Šå¨ æœŸå…ç–«æ¿€æ´»é€šè¿‡è¡¨è§‚é—ä¼ æœºåˆ¶å¯¹çªè§¦å’Œç¥ç»å‘è‚²é€šè·¯äº§ç”Ÿäº§å‰å’Œäº§åå½±å“ï¼ˆChIP-seqï¼‰**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼šimmuneã€ChIP-seqã€epigenetic
- ğŸ“ **æè¿°**ï¼šContributors : Bohan Zhu ; Gaoshan Li ; Chang LuSeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Mus musculusPrevious epidemiological research suggests that maternal immune activation (MIA) during early pregnancy is a significant risk factor for neurodevelopmental and psychiatric disorders in offspring. Epigenetic factors and chromatin-related phenomena remain largely plastic during the course of prenatal and early postnatal development, allowing a dynamic impact of environmental effects on access to genes and regulatory elements. In this study, we tested the effects of maternal infection with the mouse-adapted influenza A/WSN/33 (H1N1) virus as a MIA model. Additionally, to assess the prenatal and postnatal effects of MIA, we cross-fostered half of the neonatal mice immediately after birth.This study includes RNA-seq and ChIP-seq profiling (H3K27ac, H3K4me3) from the prefrontal cortex of MIA-exposed and control mice. RNA-seq and ChIP-seq data are submitted under separate Series and linked via sample annotations.
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE297247)

**4.** â­ **GSE297245 å¦Šå¨ æœŸå…ç–«æ¿€æ´»é€šè¿‡è¡¨è§‚é—ä¼ æœºåˆ¶å¯¹çªè§¦å’Œç¥ç»å‘è‚²é€šè·¯äº§ç”Ÿäº§å‰å’Œäº§åå½±å“ï¼ˆRNA-seqï¼‰**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼šimmuneã€RNA-seqã€epigenetic
- ğŸ“ **æè¿°**ï¼šContributors : Bohan Zhu ; Gaoshan Li ; Chang LuSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusPrevious epidemiological research suggests that maternal immune activation (MIA) during early pregnancy is a significant risk factor for neurodevelopmental and psychiatric disorders in offspring. Epigenetic factors and chromatin-related phenomena remain largely plastic during the course of prenatal and early postnatal development, allowing a dynamic impact of environmental effects on access to genes and regulatory elements. In this study, we tested the effects of maternal infection with the mouse-adapted influenza A/WSN/33 (H1N1) virus as a MIA model. Additionally, to assess the prenatal and postnatal effects of MIA, we cross-fostered half of the neonatal mice immediately after birth.This study includes RNA-seq and ChIP-seq profiling (H3K27ac, H3K4me3) from the prefrontal cortex of MIA-exposed and control mice. RNA-seq and ChIP-seq data are submitted under separate Series and linked via sample annotations.
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE297245)

**5.** â­ **GSE284605 é”ŒæŒ‡å’ŒBTBç»“æ„åŸŸåŒ…å«32 (Zbtb32) è½¬å½•å› å­ä¿ƒè¿›ç™Œç—‡ä¸­CD8+ Tç»†èƒçš„åˆ†åŒ–å’ŒåŠŸèƒ½ [ChIP-Seq]**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼šcancerã€T cellã€ChIP-seq
- ğŸ“ **æè¿°**ï¼šContributors : Birui Pan ; Ruifeng Li ; Xiaohong Zhao ; Chen DongSeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Mus musculusIn the tumor microenvironment (TME), â€œexhaustedâ€ CD8+ T cells are classified into progenitor (Tpex) and terminally exhausted (Ttex) populations. Tpex cells could be reinvigorated during immune checkpoint blockade (ICB) therapy. However, the mechanisms governing the differentiation of Tpex to Ttex remain not well understood. In this study, we identified that Zinc Finger and BTB Domain Containing 32 (Zbtb32) transcription factor, highly expressed in CD8+ Ttex subset, plays a critical role in regulating CD8+ T cells within tumors. Zbtb32, regulated by CD28 signaling, promotes the differentiation of CD8+ T cells into Ttex subset, enhancing their cytotoxicity, proliferation and anti-tumor capability. Importantly, we found a competitive DNA binding between Zbtb32 and Bcl6, another Zbtb family member promoting the Tpex program, especially in regulation of Id2 expression. Thus, our findings underscore the pivotal role of Zbtb32 in CD8+ T cell anti-tumor function, with implications in cancer immunotherapy.
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE284605)

**6.** â­ **GSE284604 é”ŒæŒ‡å’ŒBTBç»“æ„åŸŸåŒ…å«32 (Zbtb32) è½¬å½•å› å­ä¿ƒè¿›ç™Œç—‡ä¸­CD8+ Tç»†èƒçš„åˆ†åŒ–å’ŒåŠŸèƒ½ [RNA-Seq]**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼šcancerã€T cellã€RNA-seq
- ğŸ“ **æè¿°**ï¼šContributors : Birui Pan ; Xiaohong Zhao ; Ruifeng Li ; Chen DongSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusIn the tumor microenvironment (TME), â€œexhaustedâ€ CD8+ T cells are classified into progenitor (Tpex) and terminally exhausted (Ttex) populations. Tpex cells could be reinvigorated during immune checkpoint blockade (ICB) therapy. However, the mechanisms governing the differentiation of Tpex to Ttex remain not well understood. In this study, we identified that Zinc Finger and BTB Domain Containing 32 (Zbtb32) transcription factor, highly expressed in CD8+ Ttex subset, plays a critical role in regulating CD8+ T cells within tumors. Zbtb32, regulated by CD28 signaling, promotes the differentiation of CD8+ T cells into Ttex subset, enhancing their cytotoxicity, proliferation and anti-tumor capability. Importantly, we found a competitive DNA binding between Zbtb32 and Bcl6, another Zbtb family member promoting the Tpex program, especially in regulation of Id2 expression. Thus, our findings underscore the pivotal role of Zbtb32 in CD8+ T cell anti-tumor function, with implications in cancer immunotherapy.
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE284604)

**7.** â­ **GSE284603 é”ŒæŒ‡å’ŒBTBç»“æ„åŸŸåŒ…å«32 (Zbtb32) è½¬å½•å› å­ä¿ƒè¿›ç™Œç—‡ä¸­CD8+ Tç»†èƒçš„åˆ†åŒ–å’ŒåŠŸèƒ½ [ATAC-seq]**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼šcancerã€T cellã€ATAC-seq
- ğŸ“ **æè¿°**ï¼šContributors : Birui Pan ; Xiaohong Zhao ; Chen DongSeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Mus musculusIn the tumor microenvironment (TME), â€œexhaustedâ€ CD8+ T cells are classified into progenitor (Tpex) and terminally exhausted (Ttex) populations. Tpex cells could be reinvigorated during immune checkpoint blockade (ICB) therapy. However, the mechanisms governing the differentiation of Tpex to Ttex remain not well understood. In this study, we identified that Zinc Finger and BTB Domain Containing 32 (Zbtb32) transcription factor, highly expressed in CD8+ Ttex subset, plays a critical role in regulating CD8+ T cells within tumors. Zbtb32, regulated by CD28 signaling, promotes the differentiation of CD8+ T cells into Ttex subset, enhancing their cytotoxicity, proliferation and anti-tumor capability. Importantly, we found a competitive DNA binding between Zbtb32 and Bcl6, another Zbtb family member promoting the Tpex program, especially in regulation of Id2 expression. Thus, our findings underscore the pivotal role of Zbtb32 in CD8+ T cell anti-tumor function, with implications in cancer immunotherapy.
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE284603)

**8.** **GSE297440 ç”¨äºå³æ—¶ç—…æ¯’åŸºå› ç»„æµ‹åºçš„å¾®ååº”å™¨ç³»ç»Ÿ**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼šsequencingã€genome
- ğŸ“ **æè¿°**ï¼šContributors : Thomas M Hadlock ; Jacob Neice ; Chang LuSeries Type : OtherOrganism : Sus scrofa domesticusViral genome sequencing is critical for understanding viral biology, identifying strain mutations, and managing public health during pandemics. Although sequencing technologies have progressed over the years in terms of throughput and cost, a portable platform that integrates sample processing, library preparation, and sequencing remains critical for point-of-care viral sequencing that combats viral outbreaks in the field. In here, we demonstrate a semi-automated, field-deployable microreactor system to produce nanopore sequencing libraries from viral samples. The system integrates isothermal amplification, purification, and enzymatic processing within a closed-channel format, minimizing contamination risk and operational complexity. Using Senecavirus A (SVA) as a surrogate for high-consequence pathogens, we demonstrate the systemâ€™s ability to prepare sequencing libraries targeting three dispersed genomic regions comprising ~16% of the viral genome and identify single nucleotide variations with high confidence. Together with a portable nanopore sequencer, this microreactor offers a robust solution for decentralized genomic surveillance and rapid diagnostics in resource-limited or outbreak-prone environments.
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE297440)

**9.** **GSE295934 ç©ºé—´ä¸Šä¸åŒçš„ç»†èƒå’Œåˆ†å­å›¾è°±å†³å®šä¸‰é˜´æ€§ä¹³è…ºç™Œçš„é¢„å**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼šcancerã€spatially
- ğŸ“ **æè¿°**ï¼šSeries Type : OtherOrganism : Homo sapiens ; synthetic constructThis SuperSeries is composed of the SubSeries listed below.
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE295934)

**10.** **GSE295927 ç©ºé—´ä¸Šä¸åŒçš„ç»†èƒå’Œåˆ†å­æ™¯è§‚å†³å®šäº†ä¸‰é˜´æ€§ä¹³è…ºç™Œçš„é¢„å[2]**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼šcancerã€spatially
- ğŸ“ **æè¿°**ï¼šContributors : Kavitha Mukund ; Darya Veraksa ; David E Frankhouser ; Lixin Yang ; Jerneja Tomsic ; Raju Pillai ; Srijan Atti ; Zahra Mesrizadeh ; Daniel Schmolze ; Xio-Cheng Wu ; Mary-Anne LeBlanc ; Lucio Miele ; Augusto Ochoa ; Victoria Seewaldt ; Shankar SubramaniamSeries Type : OtherOrganism : Homo sapiens ; synthetic constructTriple-negative breast cancer is a prevalent breast cancer subtype with the lowest 5-year survival. Several factors contribute to its treatment response, but the inherent molecular and cellular tumor heterogeneity are increasingly acknowledged as crucial determinants. Here we report on the spatial and molecular heterogeneity underlying a retrospective, treatment-naÃ¯ve group of women with differential prognoses (17 with >15 years survival- good prognosis (GPx) and 15 with <3 years survival-poor prognosis (PPx)) profiled using GeoMXÂ® DSP. Analyses revealed that the state of epithelia and its microenvironment (TME) are transcriptionally distinct between the two groups. Invasive epithelia in GPx shows a significant increase in immune transcripts, with the TME exhibiting increased immune cell presence (via IF). PPx epithelia, in contrast, are more metabolically and translationally active, with the TME being more mesenchymal/fibrotic. Notably, pre-cancerous epithelia in PPx display a prescience of aggressiveness, as evidenced by increased EMT-signaling. We identify distinct epithelial gene signatures for PPx and GPx, that can, with high accuracy, classify samples at the time of diagnosis and are likely to inform therapy.
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE295927)

> ğŸ’¡ è¯¥æ¥æºè¿˜æœ‰ 39 æ¡å†…å®¹ï¼Œè¯¦è§ [æ–‡æœ«](#æ›´å¤š-æ•°æ®å‰æ²¿)

</div>

</details>

<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ§ª åšå®¢æ›´æ–° (4æ¡)</summary>

<div class="details-content" markdown="1">

#### è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨4æ¡ï¼‰

**1.** **æ¢ç´¢åŸºå› è¡¨è¾¾ä¸è¡°è€ä¹‹é—´çš„è”ç³»**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼šaging
- ğŸ“ **æè¿°**ï¼šAdvanced RNA sequencing reveals how transcription elongation factors like NELF and ELOA regulate gene expression and senescence, linking transcription dynamics with aging and potential anti-aging targets...
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](https://www.rna-seqblog.com/exploring-the-connection-between-gene-expression-and-aging/)

**2.** **ç§‘å­¦å®¶å‘ç°äº†ä¸€ç§å‡ç¼“ç»†èƒå†…è¡°è€çš„æ–°æ–¹æ³•ã€‚**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼šaging
- ğŸ“ **æè¿°**ï¼šA small tweak to mitochondrial energy production led to big gains in health and longevity. Mice engineered to boost a protein that helps mitochondria work more efficiently lived longer and showed better metabolism, stronger muscles, and healthier fat tissue. Their cells produced more energy while dialing down oxidative stress and inflammation tied to aging. The results hint that improving cellular power output could help slow the aging process itself.
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](https://www.sciencedaily.com/releases/2025/12/251218060557.htm)

**3.** **æ­å¼€98%ä¹‹è°œï¼šç§‘å­¦å®¶ä»¬åˆšåˆšç ´è§£äº†ä¸é˜¿å°”èŒ¨æµ·é»˜ç—…ç›¸å…³çš„â€œåƒåœ¾DNAâ€å¯†ç **
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼šAlzheimer
- ğŸ“ **æè¿°**ï¼šResearchers have revealed that so-called â€œjunk DNAâ€ contains powerful switches that help control brain cells linked to Alzheimerâ€™s disease. By experimentally testing nearly 1,000 DNA switches in human astrocytes, scientists identified around 150 that truly influence gene activityâ€”many tied to known Alzheimerâ€™s risk genes. The findings help explain why many disease-linked genetic changes sit outside genes themselves. The resulting dataset is now being used to train AI systems to predict gene control more accurately.
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](https://www.sciencedaily.com/releases/2025/12/251219093315.htm)

**4.** **æ¯å‘¨æŠ½å‡ºå‡ ä¸ªå°æ—¶å¸®åŠ©ä»–äººæˆ–è®¸å¯ä»¥å»¶ç¼“å¤§è„‘è¡°è€**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼šaging
- ğŸ“ **æè¿°**ï¼šSpending a few hours a week helping others may slow the aging of the brain. Researchers found that both formal volunteering and informal acts, like helping neighbors or relatives, were linked to noticeably slower cognitive decline over time. The benefits added up year after year and didnâ€™t require a huge time commitment. Even modest, everyday helping packed a powerful mental payoff.
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](https://www.sciencedaily.com/releases/2025/12/251218060615.htm)


</div>

</details>

## ğŸ“Š å…³é”®è¯ç»Ÿè®¡

| å…³é”®è¯ | å‡ºç°æ¬¡æ•° |
|--------|----------|
| cancer | 17 |
| RNA-seq | 8 |
| T cell | 6 |
| tumor | 5 |
| immune | 5 |
| aging | 4 |
| immunity | 4 |
| ChIP-seq | 4 |
| epigenetic | 4 |
| metabolism | 3 |
| spatially | 3 |
| regex:bacter(ia|ial|ium) | 2 |
| ATAC-seq | 2 |
| tumor microenvironment | 1 |
| sequencing | 1 |
| genome | 1 |
| antibody | 1 |
| leukemia | 1 |
| Alzheimer | 1 |
| spatial | 1 |

---

## ğŸ“ æ›´å¤šå†…å®¹

<details>
<summary><a name="æ›´å¤š-æ•°æ®å‰æ²¿"></a>ğŸ§¬ æ•°æ®å‰æ²¿ å…¶ä»–å†…å®¹ (39æ¡)</summary>

<div class="details-content" markdown="1">

- [GSE295858 ç©ºé—´ä¸Šä¸åŒçš„ç»†èƒå’Œåˆ†å­æ™¯è§‚å†³å®šäº†ä¸‰é˜´æ€§ä¹³è…ºç™Œçš„é¢„å[1]](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE295858)
- [GSE301299 å¤šç»„å­¦åˆ†æé‰´å®šå‡ºå†…åœ¨çš„ Trp53 é©±åŠ¨çš„è½¬ç§»æ€§ä¹³è…ºç™Œäºšå‹ [RNA-seq]](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE301299)
- [GSE291580 å—æ§çš„å·¥ç¨‹åŒ–å·¨å™¬ç»†èƒç„¦äº¡å¯é€šè¿‡é‡Šæ”¾æº¶ç˜¤ç»†èŒå’Œç‚ç—‡ä¿¡å·å®ç°åŸä½åŒç›¸æŠ—è‚¿ç˜¤ä½œç”¨](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE291580)
- [GSE313754 åŸºè´¨MTHFD2è°ƒæ§çº¤ç»´åŒ–-ç‚ç—‡å¾®ç¯å¢ƒï¼Œé©±åŠ¨è‚¿ç˜¤ç”Ÿé•¿å’Œå…ç–«é€ƒé€¸](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313754)
- [GSE297906 ç ”ç©¶æ°§åŒ–ä½å¯†åº¦è„‚è›‹ç™½å¯¹ CD4+ T ç»†èƒ H3K27ac è¡¨è§‚é—ä¼ æ ‡è®°çš„å½±å“](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE297906)
- [GSE295462 åˆ©ç”¨è¡¨é¢æ ‡å¿—ç‰©é‰´å®šæ•è·è½¬ç§»æ€§ä¸‰é˜´æ€§ä¹³è…ºç™Œä¸­çš„æ´»å¾ªç¯è‚¿ç˜¤ç»†èƒ](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE295462)
- [GSE235597 ç³»ç»Ÿæ€§è¯±å¯¼è®­ç»ƒå…ç–«å¯å…‹æœå®ä½“ç˜¤çš„å…ç–«æŠ‘åˆ¶å¾®ç¯å¢ƒã€‚[scRNA-Seq]](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE235597)
- [GSE233404 è¡°è€ä¾èµ–æ€§EXOSC2å¤±è°ƒåœ¨ç™Œç—‡ä¸­æŒç»­å­˜åœ¨å¹¶å…·æœ‰ä¾èµ–æ€§](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE233404)
- [GSE128468 PLPP1æŠ‘åˆ¶ä¹³è…ºç™Œè‚¿ç˜¤ç”Ÿé•¿](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE128468)
- [GSE314344 HIVæŠ‘åˆ¶ç»“æ ¸åˆ†ææ†èŒæ„ŸæŸ“çš„äººç±»å·¨å™¬ç»†èƒä¸­çš„Warburgä»£è°¢](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314344)
- [GSE311007 ç³–åŸåˆæˆé…¶2æ•²é™¤æ–‘é©¬é±¼è‚è„è‘¡è„ç³–ä»£è°¢å¢å¼º](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311007)
- [GSE292997 æ•´åˆç´ Î²1æ ‡å¿—ç€å¤šå‘æ€§ç¡¬åŒ–ç—‡ä¸­è„‘å†…æŠ—ä½“åˆ†æ³Œç»†èƒçš„å‰ä½“](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE292997)
- [GSE288602 åŠ¨è„‰ç²¥æ ·ç¡¬åŒ–é€šè¿‡å¾ªç¯é«“ç³»ç»†èƒä¸­çš„å¹²æ‰°ç´ å¯åŠ¨ï¼Œä¿ƒè¿› COVID-19 ç–¾ç—…ä¸­è¿‡åº¦çš„å…ç–«ååº”](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE288602)
- [GSE279779 NFÎºB1ç¼ºé™·ä¸Flt3é«“ç³»ç™½è¡€ç—…ç›¸å…³ï¼Œé€šè¿‡RelA:p52å’ŒSOD2è¡¨è¾¾å¤±è°ƒå¢å¼ºç»†èƒè‡ªæˆ‘æ›´æ–°èƒ½åŠ›](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE279779)
- [GSE314460 é«˜åˆ†è¾¨ç‡ä½“å†…ç»“åˆæ•°æ®æ˜¾ç¤ºï¼ŒTBP åœ¨æœ‰æˆ–æ²¡æœ‰ TFIID çš„æƒ…å†µä¸‹å‡å¯åœ¨ TATA å¯åŠ¨å­å¤„å¯åŠ¨è½¬å½• [RNA-seq]](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314460)
- [GSE313708 æ ¸å¤–æ³Œä½“ä»‹å¯¼çš„ RNA é™è§£å¯¹äº Piwi ä»‹å¯¼çš„è½¬åº§å­æ²‰é»˜è‡³å…³é‡è¦ [RNA-seq]](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313708)
- [GSE313706 æ ¸å¤–æ³Œä½“ä»‹å¯¼çš„ RNA é™è§£å¯¹äº Piwi ä»‹å¯¼çš„è½¬åº§å­æ²‰é»˜è‡³å…³é‡è¦ [ChIP-seq]](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313706)
- [GSE309627 ç¯äºŒé¸Ÿè‹·é…¸é€šè¿‡é¶å‘ PSMD3 æŠ‘åˆ¶ç™Œç—‡è½¬ç§»ï¼Œä¸”è¯¥è¿‡ç¨‹ç‹¬ç«‹äº STINGã€‚](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309627)
- [GSE307538 æ¯ä½“å…ç–«æ¿€æ´»è¯±å¯¼æ’æ²³çŒ´åä»£æä»æ ¸ä¸­é•¿æœŸã€ç»†èƒç‰¹å¼‚æ€§çš„è½¬å½•ç»„å˜åŒ–](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE307538)
- [GSE274431 æ ¸å¤–æ³Œä½“æ˜¯ Piwi-piRNA ä»‹å¯¼çš„å…±è½¬å½•åŸºå› æ²‰é»˜æ‰€å¿…éœ€çš„ [ChIP-seq]](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE274431)
- [GSE274430 æ ¸å¤–æ³Œä½“æ˜¯ Piwi-piRNA ä»‹å¯¼çš„å…±è½¬å½•åŸºå› æ²‰é»˜æ‰€å¿…éœ€çš„ [RNA-seq]](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE274430)
- [GSE314580 æŠ‘åˆ¶è„‚è´¨åˆ†è§£ä»£è°¢å†³å®šç¦é£Ÿåçš„å¯¿å‘½ [ç¦é£Ÿ RNA-Seq]](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314580)
- [GSE307511 é˜æ˜çªå˜å‹ p53 é©±åŠ¨çš„ä¹³è…ºç™Œä¸­ DCIS è¿›å±•çš„ååŒé—ä¼ äº‹ä»¶ [WGS]](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE307511)
- [GSE307509 é˜æ˜çªå˜å‹ p53 é©±åŠ¨çš„ä¹³è…ºç™Œä¸­ DCIS è¿›å±•çš„ååŒé—ä¼ äº‹ä»¶ [WES]](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE307509)
- [GSE301300 å¤šç»„å­¦åˆ†æé‰´å®šå‡ºå†…åœ¨çš„ Trp53 é©±åŠ¨çš„è½¬ç§»æ€§ä¹³è…ºç™Œäºšå‹ [WES]](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE301300)
- [GSE297459 äººç±»è†€èƒ±ç»†èƒç©ºé—´åˆ†å¸ƒå›¾](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE297459)
- [GSE278578 Î²2 è‚¾ä¸Šè…ºç´ èƒ½ä¿¡å·é€šè¿‡è¯±å¯¼ MAPK ä¾èµ–æ€§ Il1b è½¬å½•åˆºæ¿€å·¨å™¬ç»†èƒæ—©æœŸ IL-1Î² åˆ†æ³Œ [ATAC-Seq]](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE278578)
- [GSE278577 Î²2 è‚¾ä¸Šè…ºç´ èƒ½ä¿¡å·é€šè¿‡è¯±å¯¼ MAPK ä¾èµ–çš„ Il1b è½¬å½•åˆºæ¿€å·¨å™¬ç»†èƒæ—©æœŸ IL-1Î² åˆ†æ³Œ [RNA-Seq]](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE278577)
- [GSE313751 äººç±»è€å—æ€§æ ‘çªçŠ¶ç»†èƒäºšå‹å¯¹ç»†èƒæ¯’æ€§ CD4+ T ç»†èƒçš„è¯±å¯¼å‘æŒ¥ä¸åŒçš„ä½œç”¨](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313751)
- [GSE310779 ç ”ç©¶åœˆå…»å—éçŒè±¹ï¼ˆAcinonyx jubatus jubatusï¼‰çš„å¹´é¾„ã€æ€§åˆ«å’Œç–¾ç—…çš„è¡¨è§‚é—ä¼ ç”Ÿç‰©æ ‡å¿—ç‰©](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310779)
- [GSE309759 è‘¡è„ç³–ä»£è°¢è°ƒæ§äººç±»çš®å±‚ç»†èƒå¤šæ ·åŒ–å’Œæˆç†Ÿ](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309759)
- [æ¥è‡ªæ—¥å†…ç“¦ç™Œç—‡ç™»è®°å¤„çš„GSE303377ç»“ç›´è‚ ç™Œé˜Ÿåˆ—](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE303377)
- [GSE302999 æ…¢æ€§NKç»†èƒæ´»åŒ–å¯¼è‡´åŠŸèƒ½éšœç¢ï¼Œå½¢æˆç±»ä¼¼ç»„ç»‡é©»ç•™ç»†èƒçš„çŠ¶æ€ï¼Œè¿™ç§çŠ¶æ€ç”±KLF2ç¼ºé™·ä»‹å¯¼](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302999)
- [GSE297905 ç ”ç©¶æ°§åŒ–ä½å¯†åº¦è„‚è›‹ç™½å¯¹CD4+ Tç»†èƒåŸºå› è¡¨è¾¾çš„å½±å“](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE297905)
- [GSE297904 ç ”ç©¶æ°§åŒ–ä½å¯†åº¦è„‚è›‹ç™½ (oxLDL) å¯¹ CD4+ T ç»†èƒæŸ“è‰²è´¨å¯åŠæ€§çš„å½±å“](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE297904)
- [GSE297058 é—ä¼ æ€§æ…¢æ€§èƒ°è…ºç‚è¯±å¯¼çš„å¯å¡‘æ€§ä¸çªå˜å‹ Kras ååŒä½œç”¨ï¼Œä¿ƒè¿›æ—©æœŸèƒ°è…ºç™Œçš„å‘ç”Ÿ](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE297058)
- [GSE235598 ç³»ç»Ÿæ€§è¯±å¯¼è®­ç»ƒå…ç–«å¯å…‹æœå®ä½“ç˜¤çš„å…ç–«æŠ‘åˆ¶å¾®ç¯å¢ƒ](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE235598)
- [GSE235364 ç³»ç»Ÿæ€§è¯±å¯¼è®­ç»ƒå…ç–«å¯å…‹æœå®ä½“ç˜¤çš„å…ç–«æŠ‘åˆ¶å¾®ç¯å¢ƒã€‚[scMULTIome]](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE235364)
- [GSE112017 å»æ³›ç´ åŒ–é…¶ USP20 é€šè¿‡ç¨³å®š SLUG ä¿ƒè¿›ä¹³è…ºç™Œè½¬ç§»](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE112017)

</div>

</details>

---

*ğŸ“… æŠ¥å‘Šç”Ÿæˆæ—¶é—´ï¼š2025-12-20 21:33*  
*ğŸ¤– ç”± GitHub Actions è‡ªåŠ¨ç”Ÿæˆ*